IT8519992A0 - Derivati alcanolaminici e inibitori di aggregazione delle piastrine contenenti gli stessi come un ingrediente attivo. - Google Patents

Derivati alcanolaminici e inibitori di aggregazione delle piastrine contenenti gli stessi come un ingrediente attivo.

Info

Publication number
IT8519992A0
IT8519992A0 IT8519992A IT1999285A IT8519992A0 IT 8519992 A0 IT8519992 A0 IT 8519992A0 IT 8519992 A IT8519992 A IT 8519992A IT 1999285 A IT1999285 A IT 1999285A IT 8519992 A0 IT8519992 A0 IT 8519992A0
Authority
IT
Italy
Prior art keywords
active ingredient
same
platelet aggregation
aggregation inhibitors
inhibitors containing
Prior art date
Application number
IT8519992A
Other languages
English (en)
Other versions
IT1185097B (it
Inventor
Keiko Takahashi
Yasushi Suwabe
Toshio Wakabayashi
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5379684A external-priority patent/JPS60197642A/ja
Priority claimed from JP2653385A external-priority patent/JPS61189252A/ja
Application filed by Terumo Corp filed Critical Terumo Corp
Publication of IT8519992A0 publication Critical patent/IT8519992A0/it
Application granted granted Critical
Publication of IT1185097B publication Critical patent/IT1185097B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT19992/85A 1984-03-21 1985-03-21 Derivati alcanolaminici e inibitori di aggregazione delle piastrine contenenti gli stessi come un ingrediente attivo IT1185097B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5379684A JPS60197642A (ja) 1984-03-21 1984-03-21 エタノ−ルアミン誘導体およびこれを有効成分として含有する血小板凝集抑制剤
JP2653385A JPS61189252A (ja) 1985-02-15 1985-02-15 アルカノ−ルアミン誘導体およびこれを有効成分として含有する血小板凝集抑制剤

Publications (2)

Publication Number Publication Date
IT8519992A0 true IT8519992A0 (it) 1985-03-21
IT1185097B IT1185097B (it) 1987-11-04

Family

ID=26364321

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19992/85A IT1185097B (it) 1984-03-21 1985-03-21 Derivati alcanolaminici e inibitori di aggregazione delle piastrine contenenti gli stessi come un ingrediente attivo

Country Status (5)

Country Link
US (1) US4619938A (it)
EP (1) EP0161422B1 (it)
BE (1) BE901987A (it)
DE (1) DE3568427D1 (it)
IT (1) IT1185097B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2609026B1 (fr) * 1986-12-31 1989-03-31 Cird Amides de l'acide eicosatetraynoique et leur application en pharmacie et en cosmetique
US4880788A (en) * 1987-10-30 1989-11-14 Baylor College Of Medicine Method for preventing and treating thrombosis
US5618955A (en) * 1992-11-30 1997-04-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Fatty acid derivatives and pharmaceutical compositions containing same
IL103932A (en) * 1992-11-30 1997-02-18 Yissum Res & Dev Fatty acid and pharmaceutical compositions containing them
CA2220091C (en) * 1995-05-01 2011-01-04 Scotia Holdings Plc Nicotinic acid esters and pharmaceutical compositions containing them
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
US20070154543A1 (en) * 2003-04-16 2007-07-05 Kyorin Pharmaceutical Co., Ltd Solid preparation for oral use
WO2009109973A2 (en) 2008-03-04 2009-09-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compounds and methods of treating obesity
KR101685734B1 (ko) 2009-09-01 2016-12-12 카타베이시스 파마슈티칼즈, 인코포레이티드 지방산 나이아신 접합체 및 그의 용도
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
CN103113253A (zh) * 2013-01-28 2013-05-22 国家海洋局第三海洋研究所 一种不饱和脂肪酸醇胺衍生物及其制备方法与应用
CN103833587B (zh) * 2014-03-26 2016-04-13 国家海洋局第三海洋研究所 一锅法制备高不饱和脂肪酰丙醇胺的方法
CN105230617B (zh) * 2015-09-25 2017-05-10 浙江大学 亚油酰乙醇胺在提高植物灰霉病和细菌性叶斑病抗性中的应用
CN105230616B (zh) * 2015-09-25 2017-05-10 浙江大学 廿二碳五烯酸乙醇胺在提高植物灰霉病抗性中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2304830A (en) * 1939-12-29 1942-12-15 Emulsol Corp Amides of heterocyclic carboxylic acids
CH441309A (de) * 1963-04-16 1967-08-15 Hoffmann La Roche Verfahren zur Herstellung von neuen Äthern
GB1089189A (en) * 1964-09-23 1967-11-01 Koninklijke Pharma Fab Nv Ethers of -(2-pyridyl)benzyl alcohols
CH464197A (de) * 1965-04-06 1968-10-31 Globopharm Ag Verfahren zur direkten Darstellung von freien Estern der B-Pyridincarbonsäure mit Aminoalkoholen
DE1806010A1 (de) * 1968-10-30 1970-05-21 Huels Chemische Werke Ag Verfahren zur Herstellung hellfarbiger Fettsaeureamidoaethylate
DE2129425C3 (de) * 1971-06-14 1975-05-22 Chemische Werke Huels Ag, 4370 Marl Verfahren zur Herstellung von Fettsäureäthanolamiden
HU165022B (it) * 1972-04-28 1974-06-28
US3985875A (en) * 1974-01-12 1976-10-12 Dainippon Pharmaceutical Co., Ltd. ω-(N-acylamino)alkylphosphoryl ethanolamines, pharmaceutical compositions containing them, and their uses
FR2346010A2 (fr) * 1976-03-29 1977-10-28 Fabre Sa Pierre Procede de preparation du chlorhydrate de n-nicotinoyl o-p-chloro phenoxy isobutanoyl ethanol amine, utile dans le traitement des dislipidemies et la prevention de l'atherosclerose
FR2392008A1 (fr) * 1977-05-02 1978-12-22 Fabre Sa Pierre Nouvelles formes modulees de medicaments utilisant les n-hydroxy alcoyl pyridine carboxamides comme vecteurs

Also Published As

Publication number Publication date
EP0161422A1 (en) 1985-11-21
EP0161422B1 (en) 1989-03-01
US4619938A (en) 1986-10-28
IT1185097B (it) 1987-11-04
BE901987A (fr) 1985-07-16
DE3568427D1 (en) 1989-04-06

Similar Documents

Publication Publication Date Title
IT1203806B (it) Derivati del tiazolo,loro preparazione e composizioni farmaceutiche che li contengono
IT8319164A0 (it) Derivati della 5-metiltiopirimidina, processo diloro preparazione e fungicidi contenenti gli stessi come ingredienti attivi.
IT8519992A0 (it) Derivati alcanolaminici e inibitori di aggregazione delle piastrine contenenti gli stessi come un ingrediente attivo.
IT8667183A0 (it) Derivati di anilina terapeuticamente attivi,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8423564A0 (it) Derivati della 7-carbossimetossi-furo-(3,4-c)-piri dina, loro preparazione e composizioni farmaceutiche che licontengono.
IT8319857A0 (it) Agenti antiflogistici/antipiretici/analgesici contenenti derivati di teobromina o teofillina come ingrediente attivo.
IT1206505B (it) Nuovi derivati benzotiazepinonici, metodo per la loro preparazione e composizioni farmaceutiche che licontengono.
IT1215156B (it) Derivati di delta 2-1,2,4-triazolin5-one e composizioni erbicide cheli contengono
IT8720619A0 (it) Derivati 1-(idrossistiril)-5h2,3-benzodiazepinici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
MX9203639A (es) 3-fenoxi-1-azetidincarboxamidas y composiciones farmaceuticas que las contienen.
IT8522359A0 (it) Composizioni farmaceutiche che li derivati di vitamina d,contengono e loro precursori.
IT8319027A0 (it) Derivati amino-alchil-solfonici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8222911A0 (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
IT8621526A0 (it) Loro preparazione e medicinali che derivati di metilendiossifenantrene li contengono. e stilbene, procedimento per la
IT8320920A0 (it) Derivati di cicloalcani, procedimento per la loro preparazione e composizioni che licontengono.
IT1168389B (it) Derivati di alcandioli con attivita' ipolipidemizzante,metodi per la loro preparazione e composizioni farmaceutiche che li contengono
IT8022601A0 (it) Derivati 3h-naft[1.2-d]-imidazolici il procedimento per la loro preparazione,il loro uso come agenti antiinfiammatori e le composizioni farmaceutiche che li contengono
IT8520483A0 (it) Derivati di apovincaminolo, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8119329A0 (it) Derivati di imidazol-idrazoni utili come farmaci.
IT8323010A0 (it) Derivati 15-cicloalifatici di 13,14-dideidro carboprostacicline eprocedimento per la loro preparazione.
IT8323844A0 (it) Derivati della cisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8819814A0 (it) Derivati n_cicloalchilaminoetilbenzamidici, loro preparazione e composizioni farmaceutiche che li contengono.
IT1157301B (it) Derivati di apovincaminolo, relativo procedimento di preparazione e composizioni farmaceutiche contenenti gli stessi
IT8421627A1 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo
IT1174788B (it) Derivati di amminoglucosidi,loro preparazione e loro impiego come medicamenti

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950330